← Open Payments lookup

EDWARD BARIAS: Open Payments

NPI 1689007700 · JUPITER, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,968 in 172 payments from 20 companies in 2025. Trend: 2023 $3,011 · 2024 $4,487 · 2025 $3,968

Food & beverage: $3,968
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.16$651
ABBVIE INC.34$495
Otsuka America Pharmaceutical, Inc.10$406
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)21$387
Axsome Therapeutics, Inc.12$357
Alkermes, Inc.16$340
Takeda Pharmaceuticals U.S.A., Inc.8$193
E.R. Squibb & Sons, L.L.C.11$165
Vanda Pharmaceuticals Inc.9$162
Janssen Pharmaceuticals, Inc6$140

Products named: INGREZZA, VRAYLAR, REXULTI, CAPLYTA, Auvelity, ARISTADA, TRINTELLIX, COBENFY.

Industry payments across FL — which companies pay providers there.